人乳头瘤病毒疫苗用于治疗顽固性皮肤疣
Human papillomavirus vaccination for recalcitrant cutaneous warts.
作者信息
Karofylakis Emmanouil, Gkrania-Klotsas Effrossyni, Kumararatne Dinakantha
机构信息
Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Immunology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
出版信息
IJID Reg. 2024 Nov 10;13:100488. doi: 10.1016/j.ijregi.2024.100488. eCollection 2024 Dec.
Abstract
•Recalcitrant warts affect immunocompetent and immunocompromised persons.•The optimal approach to refractory warts remains unclear.•Human papillomavirus vaccination is a promising therapy for recalcitrant warts.
摘要
•顽固性疣可影响免疫功能正常和免疫功能低下的人群。
•对于难治性疣的最佳治疗方法仍不明确。
•人乳头瘤病毒疫苗接种是治疗顽固性疣的一种有前景的疗法。
Zotero 插件